Kidney Transplant
📧 Sign up to get email alerts when something new happens for Kidney Transplant.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-12-21Clinical Trial Update: Transversus Abdominis Plane Block During Kidney Transplant Surgery [Phase 4]
A Phase 4 clinical trial evaluating transversus abdominis plane block during kidney transplant surgery has completed.
-
FDA approval · 2018-12-19FDA Approved: ENVARSUS XR — Supplemental Application (Veloxis Pharmaceuticals, Inc)
The FDA approved a supplemental application for ENVARSUS XR (Tacrolimus) submitted by Veloxis Pharmaceuticals, Inc.
-
CLINICAL_TRIALS trial_result · 2018-10-15Clinical Trial Update: A Study to Compare the Finger Prick Whole Blood MITRA Assay Method With the Established Venepuncture Whole Blood Method for Quantitative Determination of Tacrolimus Blood Concentrations in Transplant Patients [Phase 4]
Phase 4 clinical trial comparing finger-prick whole blood MITRA assay with standard venipuncture method for quantifying tacrolimus in transp…
-
CLINICAL_TRIALS trial_result · 2018-06-13Clinical Trial Update: The Frequency and Risk Factors of Delayed Graft Function
This clinical trial update reports on how frequently delayed graft function occurs after kidney transplantation and the factors that increas…
-
FDA approval · 2018-04-16FDA Approved: TACROLIMUS — Original Application (Glenmark Pharmaceuticals Inc., USA)
The FDA approved Glenmark Pharmaceuticals' generic tacrolimus (ANDA210393) as an original application, enabling its use to prevent organ tra…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-03-16Clinical Trial Update: Tacrolimus to Sirolimus Conversion for Delayed Graft Function [Phase 4]
Phase 4 trial investigating conversion from tacrolimus to sirolimus for delayed graft function in kidney transplant; study terminated with r…
-
CLINICAL_TRIALS trial_result · 2017-12-13Clinical Trial Update: MMF vs. AZA for Kidney Transplantation [Phase 4]
Phase 4 trial comparing mycophenolate mofetil (MMF) versus azathioprine (AZA) in kidney transplant recipients has completed.
-
CLINICAL_TRIALS trial_result · 2017-11-14Clinical Trial Update: Dosing Regimen of Eculizumab Added to Conventional Treatment in Positive Crossmatch Deceased Donor Kidney Transplant [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluated dosing regimens of eculizumab added to conventional treatment in positive crossmatch deceased donor kid…
-
CLINICAL_TRIALS trial_result · 2017-06-15Clinical Trial Update: Effects of Sevoflurane and Desflurane on Treg [Phase 2]
Phase 2 clinical trial evaluating how sevoflurane and desflurane influence regulatory T cells in kidney transplant settings; the study is co…
-
CLINICAL_TRIALS trial_result · 2017-04-06Clinical Trial Update: Mycophenolate Mofetil and Rapamycin as Secondary Intervention vs. Continuation of Calcineurin Inhibitors in Patients at Risk for Chronic Renal Allograft Failure [Phase 4]
A Phase 4 clinical trial evaluating whether switching to mycophenolate mofetil with rapamycin versus continuing calcineurin inhibitors impro…
-
CLINICAL_TRIALS research · 2017-01-30Clinical Trial Update: Early Conversion From CNI to Belatacept in Renal Transplant Recipients With Delayed and Slow Graft Function [Phase 2]
Phase 2 trial assessing early conversion from calcineurin inhibitors to belatacept in renal transplant recipients with delayed graft functio…
-
CLINICAL_TRIALS trial_result · 2016-12-15Clinical Trial Update: Tacrolimus/Everolimus Versus Tacrolimus/Enteric-Coated Mycophenolate Sodium [Phase 3]
Phase 3 trial comparing tacrolimus with everolimus versus tacrolimus with enteric-coated mycophenolate sodium in kidney transplant patients;…
-
FDA approval · 2016-06-13FDA Approved: ENVARSUS XR — Supplemental Application (Veloxis Pharmaceuticals, Inc)
FDA approved a supplemental application for ENVARSUS XR (tacrolimus) from Veloxis Pharmaceuticals, Inc.
-
CLINICAL_TRIALS trial_result · 2016-05-12Clinical Trial Update: Organ Preservation Media Investigation [Phase 1]
Phase 1 clinical trial evaluating organ preservation media for kidney transplant has been completed. The study was sponsored by the Universi…
-
CLINICAL_TRIALS trial_result · 2016-02-22Clinical Trial Update: Pharmacokinetic Studies of Tacrolimus in Transplant Patients [Phase 4]
Phase 4 pharmacokinetic studies of tacrolimus in kidney and liver transplant recipients have been completed.
-
FDA approval · 2015-12-16FDA Approved: ASTAGRAF XL — Supplemental Application (Astellas Pharma US, Inc.)
The FDA approved a supplemental application for ASTAGRAF XL (tacrolimus extended-release capsules) to support an expanded use in preventing …
-
CLINICAL_TRIALS trial_result · 2015-04-14Clinical Trial Update: Comparison of ATG to Thymoglobuline in Renal Transplantation [Phase 4]
A Phase 4 clinical trial comparing antithymocyte globulin (ATG) to Thymoglobulin in kidney transplantation has completed.
-
CLINICAL_TRIALS research · 2015-03-04Clinical Trial Update: Impact of CYP3A5 Gene Polymorphisms on Tacrolimus Concentrations and Outcomes in Thai Transplant Recipients
A clinical trial update examining how CYP3A5 gene variants affect tacrolimus blood levels and outcomes in Thai kidney transplant recipients.
-
CLINICAL_TRIALS trial_result · 2014-12-03Clinical Trial Update: Multicenter, Randomized, Open-label Study to Assess Whether Treatment With Mycophenolate Sodium (MPS) Allows Higher Dose Optimization Versus Mycophenolate Mofetil (MMF) Leading to a Dose Reduction of Tacrolimus. Maximiza Study. [Phase 4]
Phase 4 multicenter randomized trial comparing mycophenolate sodium versus mycophenolate mofetil to assess dose optimization and potential t…
-
CLINICAL_TRIALS research · 2014-09-25Clinical Trial Update: Evaluate Efficacy Study of Combination Therapy of Everolimus and Low Dose Tacrolimus in Renal Allograft Recipients [Phase 4]
Clinical trial evaluating the combination of everolimus and low-dose tacrolimus in kidney transplant recipients (Phase 4).
-
CLINICAL_TRIALS trial_result · 2014-06-06Clinical Trial Update: Non-inferiority Study of Safety and Efficacy of Everolimus With Low Dose Tacrolimus to Mycophenolate Mofetil With Standard Dose Tacrolimus in Kidney Transplant Recipients [Phase 3]
Phase 3 non-inferiority trial comparing everolimus with low-dose tacrolimus versus mycophenolate mofetil with standard-dose tacrolimus in ki…
-
FDA approval · 2014-02-11FDA Approved: ASTAGRAF XL — Supplemental Application (Astellas Pharma US, Inc.)
FDA approved a supplemental application for ASTAGRAF XL (tacrolimus extended-release capsules) from Astellas Pharm US, Inc.
-
CLINICAL_TRIALS trial_result · 2013-12-19Clinical Trial Update: PK-PD Study of Mycophenolic Acid (CellCept) in Pediatric Kidney Transplant Patients
A pharmacokinetic and pharmacodynamic study of mycophenolate mofetil (CellCept) in pediatric kidney transplant recipients has completed.
-
CLINICAL_TRIALS trial_result · 2013-03-01Clinical Trial Update: Planned Conversion From TAC to SRL-based Regimen in de Novo Kidney Transplant Recipients [Phase 4]
A Phase 4 trial in de novo kidney transplant recipients that evaluated converting from tacrolimus to a sirolimus-based regimen has completed…
-
CLINICAL_TRIALS trial_result · 2013-02-26Clinical Trial Update: Pediatric Kidney Transplant Study of Sirolimus, Mycophenolate Mofetil, and Corticosteroids vs Calcineurin Inhibitor Based Immunosuppression [NA]
Pediatric kidney transplant study comparing sirolimus, mycophenolate mofetil, and corticosteroids against calcineurin inhibitor-based immuno…